Guide to Starting and Adjusting Insulin Therapy
Start basal insulin at 10 units per day or 0.1-0.2 units/kg/day, titrate by 10-15% or 1-2 units every 2-3 days based on fasting glucose, and add prandial insulin when basal exceeds 0.5 units/kg/day or when postprandial glucose remains >180 mg/dL despite optimal fasting control. 1, 2
When to Initiate Insulin
Begin insulin therapy immediately if:
- A1C >10% (>86 mmol/mol) or blood glucose ≥300 mg/dL (≥16.7 mmol/L)
- Symptoms of hyperglycemia are present (polyuria, polydipsia, weight loss)
- Type 1 diabetes cannot be excluded 1
Otherwise, consider insulin after GLP-1 receptor agonists have been tried first, as these agents provide comparable glucose lowering with weight loss benefits rather than weight gain 1.
Starting Basal Insulin
Initial Dosing
- 10 units per day (simple, fixed approach), OR
- 0.1-0.2 units/kg/day (weight-based approach) 2, 3
- Can be given at any time of day, but must be consistent 4
Basal Insulin Selection
Long-acting analogs (glargine, degludec, detemir) are preferred over NPH due to:
- Lower hypoglycemia risk
- More predictable duration of action
- Greater dosing flexibility 3
Exception: NPH may be preferred for steroid-induced hyperglycemia when dosed in the morning 1
Titrating Basal Insulin
Standard Titration Protocol
Adjust every 2-3 days based on fasting glucose 2, 3:
- Increase by 10-15% or 1-2 units if fasting glucose above target
- Decrease by 10-20% if hypoglycemia occurs (<70 mg/dL)
- Decrease by 4 units or 10% if A1C <8% and patient is at goal 1
Target fasting glucose: 90-130 mg/dL (5.0-7.2 mmol/L) 4
Recognizing "Overbasalization"
Stop increasing basal insulin and add prandial insulin when:
- Basal dose exceeds 0.5 units/kg/day, OR
- Postprandial glucose >180 mg/dL (>10 mmol/L) despite fasting glucose at goal, OR
- BeAM score >50 mg/dL (bedtime glucose minus morning prebreakfast glucose) 2
This indicates basal insulin is optimized and mealtime coverage is needed rather than more basal insulin.
Adding Prandial (Rapid-Acting) Insulin
Initiation Strategy - Two Approaches:
Option 1: Stepwise Addition (Preferred for simplicity)
- Start with one injection before the largest meal or meal with highest carbohydrate content
- Dose: 10% of basal insulin dose or 5 units 2
- Add to additional meals as needed when postprandial glucose remains >180 mg/dL 4, 5
Option 2: Full Basal-Bolus from Start
- Add prandial insulin to all three meals simultaneously
- Split total daily insulin: 50% basal, 50% prandial (divided among meals) 2
Prandial Insulin Selection
Rapid-acting analogs preferred (lispro, aspart, glulisine) over regular insulin due to faster onset matching meal absorption 2
Titrating Prandial Insulin
Adjust every 2-3 days based on the glucose reading before the next meal or 2 hours postprandial 2:
For Hyperglycemia:
- Pre-midday glucose >110 mg/dL: Increase morning dose by 10-20%
- Pre-evening glucose >140 mg/dL: Increase midday dose by 10-20%
- Bedtime glucose >140 mg/dL: Increase evening dose by 10-20% 2
For Hypoglycemia (<70 mg/dL):
- Pre-midday hypoglycemia: Decrease morning dose by 10-20%
- Pre-evening hypoglycemia: Decrease midday dose by 10-20%
- Bedtime hypoglycemia: Decrease evening dose by 10-20% 2
Alternative: Premixed Insulin
Consider if patient prefers fewer injections and has regular meal schedule:
- Start at 0.2-0.3 units/kg/day total
- Give 2/3 before breakfast, 1/3 before dinner 2
- Titrate by 2 units every 2-3 days based on fasting glucose
Caveat: Less flexible, higher hypoglycemia risk, requires consistent meal timing 2
Sick-Day Management
During Illness:
- Continue basal insulin - never stop completely
- Monitor glucose more frequently (every 4-6 hours)
- May need to increase insulin by 10-20% due to stress hyperglycemia
- Maintain hydration
- Check for ketones if glucose persistently >250 mg/dL
Hypoglycemia Treatment:
- Conscious patient: 15-20g oral glucose (tablets, juice)
- Unconscious/unable to swallow: Glucagon injection (ready-to-use formulations available) or intranasal glucagon 2
- Recheck glucose in 15 minutes and retreat if needed
Common Pitfalls to Avoid
- Therapeutic inertia: Don't delay titration - adjust every 2-3 days until at goal 1
- Over-basalization: Recognize when to add prandial rather than continuing to increase basal 2
- Ignoring hypoglycemia patterns: Always investigate and reduce dose by 10-20% 1, 2
- Combining GLP-1 RA with DPP-4 inhibitor: No added benefit; use GLP-1 RA alone 1
- Stopping insulin during illness: Maintain basal insulin even when not eating
Emerging Options
Weekly insulins (icodec, efsitora) show promise for reducing injection burden with comparable efficacy to daily basal insulin, though not yet FDA-approved in the US 2. These require titration every 1-4 weeks rather than every 2-3 days.